The efficacy of the PD-L1/PD-1 pathway in pain relief has been corroborated in diverse pain models, including the improvement effect of PD-L1/PD-1 activation on inflammatory pain, neuropathic pain, and cancer pain, indicating that activation of PD-L1/PD-1 may have broad applicability for treating pain. Here, CD274 is linked to cancer.